Table 1.
Baseline characteristics of patients
| Total sample n = 52 | |
|---|---|
| Age (years) | 66.4 ± 8.7 |
| Male n (%) | 31 (60%) |
| BMI | 29.2 ± 4.1 |
| Hypertension n (%) | 45 (87%) |
| Diabetes mellitus n (%) | 15 (29%) |
| Heart failure | 26 (50%) |
| Atrial fibrillation | 9 (17%) |
| Hypercholesterolemia n (%) | 22 (42%) |
| Planned coronary angiography n (%) | 12 (23%) |
| Emergency coronary angiography n (%) | 40 (77%) |
| Indication for PCI at index admission n (%) | |
| STEMI | 1 (2%) |
| NSTEMI | 9 (17%) |
| UA | 35 (67%) |
| Arterial stenosis n (%) | 19 (37%) |
| Serum creatinine at admission (μmol/L) | 81.0 ± 20.0 |
| Mean eGFR at admission (mL/min/1.73 m2) | 83.4 ± 20.7 |
| eGFR at admission < 60 mL/min/1.73 m2 | 7 (13%) |
| Mean contrast-medium volume | 111.7 ± 88.7 |
| Serum NGAL at admission (ng/mL) | 201.8 (156.5–299.9) |
| Serum KIM-1 at admission (ng/mL) | 130.2 (42.4–341.9) |
| Serum IL-18 at admission (ng/mL) | 261.6 (241.7–365.7) |
| Serum L-FABP at admission (ng/mL) | 4.7 (2.7–5.0) |
STEMI ST elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, UA unstable angina